Literature DB >> 25041171

Increased Meningeal T and Plasma Cell Infiltration is Associated with Early Subpial Cortical Demyelination in Common Marmosets with Experimental Autoimmune Encephalomyelitis.

Nadine Kramann1, Katharina Neid, Lena Menken, Christina Schlumbohm, Christine Stadelmann, Eberhard Fuchs, Wolfgang Brück, Christiane Wegner.   

Abstract

Subpial cortical demyelination (SCD) accounts for the greatest proportion of demyelinated cortex in multiple sclerosis (MS). SCD is already found in biopsy cases with early MS and in marmosets with experimental autoimmune encephalomyelitis (EAE), but the pathogenesis of SCD is not well understood. The objective of this study was to investigate whether and, if so, which meningeal inflammatory cells were associated with early SCD in marmosets with EAE. Immunohistochemistry was performed to analyze brain samples from eight control animals and eight marmosets immunized with myelin oligodendrocyte glycoprotein. Meningeal T, B and plasma cells were quantified adjacent to SCD, normal-appearing EAE cortex (NAC) and control marmoset cortex. SCD areas appeared mostly hypocellular with low-grade microglial activation. In marmosets with EAE, meninges adjacent to SCD showed significantly increased T cells paralleled by elevated plasma cells, but unaltered B cell numbers compared with NAC. The elevation of meningeal T and plasma cells was a specific finding topographically associated with SCD, as the meninges overlying NAC displayed similarly low T, B and plasma cell numbers as control cortex. These findings suggest that local meningeal T and plasma cell infiltration contributes to the pathogenesis of SCD in marmosets with EAE.
© 2014 International Society of Neuropathology.

Entities:  

Keywords:  cortical demyelination; experimental autoimmune encephalomyelitis; marmoset; meningeal inflammation; multiple sclerosis; neuropathology

Mesh:

Substances:

Year:  2014        PMID: 25041171     DOI: 10.1111/bpa.12180

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  7 in total

1.  Immunopathology of the optic nerve in multiple sclerosis.

Authors:  Laura Fernández Blanco; Manuel Marzin; Alida Leistra; Paul van der Valk; Erik Nutma; Sandra Amor
Journal:  Clin Exp Immunol       Date:  2022-08-19       Impact factor: 5.732

Review 2.  Advanced MRI and staging of multiple sclerosis lesions.

Authors:  Martina Absinta; Pascal Sati; Daniel S Reich
Journal:  Nat Rev Neurol       Date:  2016-04-29       Impact factor: 42.937

3.  Ultrahigh-resolution MRI Reveals Extensive Cortical Demyelination in a Nonhuman Primate Model of Multiple Sclerosis.

Authors:  Maxime Donadieu; Hannah Kelly; Diego Szczupak; Jing-Ping Lin; Yeajin Song; Cecil C C Yen; Frank Q Ye; Hadar Kolb; Joseph R Guy; Erin S Beck; Steven Jacobson; Afonso C Silva; Pascal Sati; Daniel S Reich
Journal:  Cereb Cortex       Date:  2021-01-01       Impact factor: 5.357

Review 4.  Antibody Therapies for Progressive Multiple Sclerosis and for Promoting Repair.

Authors:  Joachim Havla; Reinhard Hohlfeld
Journal:  Neurotherapeutics       Date:  2022-03-14       Impact factor: 6.088

5.  The chronically inflamed central nervous system provides niches for long-lived plasma cells.

Authors:  Karolin Pollok; Ronja Mothes; Carolin Ulbricht; Alina Liebheit; Jan David Gerken; Sylvia Uhlmann; Friedemann Paul; Raluca Niesner; Helena Radbruch; Anja Erika Hauser
Journal:  Acta Neuropathol Commun       Date:  2017-11-25       Impact factor: 7.801

6.  Regulated Production of CXCL13 within the Central Nervous System.

Authors:  David N Irani
Journal:  J Clin Cell Immunol       Date:  2016-10-05

Review 7.  The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders.

Authors:  Silke Häusser-Kinzel; Martin S Weber
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.